Immunovant Inc. $(IMVT)$ is currently at $25.40, up $3.76 or 17.34%
--Would be highest close since Dec. 26, 2024, when it closed at $25.73
--On pace for largest percent increase since Sept. 26, 2023, when it rose 97.04%
--Currently up four of the past five days
--Up 57.6% month-to-date; on pace for best month since Sept. 2023, when it rose 69.04%
--Up 2.56% year-to-date; on pace for best year since 2023, when it rose 137.35%
--Down 51.8% from its all-time closing high of $52.71 on Nov. 17, 2020
--Down 13.17% from 52 weeks ago (Oct. 31, 2024), when it closed at $29.26
--Down 19.14% from its 52-week closing high of $31.42 on Nov. 6, 2024
--Up 90.87% from its 52-week closing low of $13.31 on April 8, 2025
--Traded as high as $26.17; highest intraday level since Dec. 26, 2024, when it hit $26.46
--Up 20.88% at today's intraday high; largest intraday percent increase since Sept. 26, 2023, when it rose as much as 105.72%
All data as of 2:19:40 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 30, 2025 14:22 ET (18:22 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.